CN100501404C - ELISA kit for detecting beta-stimulants and detection method thereof - Google Patents
ELISA kit for detecting beta-stimulants and detection method thereof Download PDFInfo
- Publication number
- CN100501404C CN100501404C CNB2005100867690A CN200510086769A CN100501404C CN 100501404 C CN100501404 C CN 100501404C CN B2005100867690 A CNB2005100867690 A CN B2005100867690A CN 200510086769 A CN200510086769 A CN 200510086769A CN 100501404 C CN100501404 C CN 100501404C
- Authority
- CN
- China
- Prior art keywords
- beta
- stimulants
- enzyme
- solution
- enzyme linked
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000021 stimulant Substances 0.000 title claims description 68
- 238000001514 detection method Methods 0.000 title abstract description 11
- 238000008157 ELISA kit Methods 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 57
- 108090000790 Enzymes Proteins 0.000 claims abstract description 57
- 239000007788 liquid Substances 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 35
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229960001117 clenbuterol Drugs 0.000 claims abstract description 33
- 239000000243 solution Substances 0.000 claims abstract description 30
- 239000012086 standard solution Substances 0.000 claims abstract description 20
- 238000012360 testing method Methods 0.000 claims abstract description 19
- 239000000758 substrate Substances 0.000 claims abstract description 15
- 238000004140 cleaning Methods 0.000 claims abstract description 8
- 239000000523 sample Substances 0.000 claims description 37
- 230000001900 immune effect Effects 0.000 claims description 24
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 19
- 238000002835 absorbance Methods 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 238000002965 ELISA Methods 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 17
- 239000008363 phosphate buffer Substances 0.000 claims description 16
- 239000000427 antigen Substances 0.000 claims description 15
- 102000036639 antigens Human genes 0.000 claims description 15
- 108091007433 antigens Proteins 0.000 claims description 15
- 239000000872 buffer Substances 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 13
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 11
- 241001465754 Metazoa Species 0.000 claims description 11
- 102000014914 Carrier Proteins Human genes 0.000 claims description 10
- 108010078791 Carrier Proteins Proteins 0.000 claims description 10
- 108010088751 Albumins Proteins 0.000 claims description 9
- 102000009027 Albumins Human genes 0.000 claims description 9
- 230000008878 coupling Effects 0.000 claims description 9
- 238000010168 coupling process Methods 0.000 claims description 9
- 238000005859 coupling reaction Methods 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 238000011534 incubation Methods 0.000 claims description 8
- 239000003550 marker Substances 0.000 claims description 8
- 239000012488 sample solution Substances 0.000 claims description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 150000008064 anhydrides Chemical class 0.000 claims description 6
- 238000002203 pretreatment Methods 0.000 claims description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 3
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims description 3
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 108010058846 Ovalbumin Proteins 0.000 claims description 3
- 108010071390 Serum Albumin Proteins 0.000 claims description 3
- 102000007562 Serum Albumin Human genes 0.000 claims description 3
- 238000005917 acylation reaction Methods 0.000 claims description 3
- 239000012675 alcoholic extract Substances 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 claims description 3
- 229940092253 ovalbumin Drugs 0.000 claims description 3
- 229940014800 succinic anhydride Drugs 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000010998 test method Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 238000002372 labelling Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 230000006835 compression Effects 0.000 abstract 2
- 238000007906 compression Methods 0.000 abstract 2
- 239000012224 working solution Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- 241000283705 Capra hircus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PWUBONDMIMDOQY-UHFFFAOYSA-N acetonitrile;hydrochloride Chemical compound Cl.CC#N PWUBONDMIMDOQY-UHFFFAOYSA-N 0.000 description 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 229960002052 salbutamol Drugs 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004186 food analysis Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- -1 phosphate ester Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003822 preparative gas chromatography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention relates to an enzyme linked immune test kit for detecting beta-excitant class medicines, which comprises an enzyme labelling plate coated with a beta-excitant class medicine, an The invention relates to an enzyme immune agent box for detecting beta-excitant drugs, which comprises: enzyme mark plate which coats beta-excitant drugs, enzyme mark antibody, clenobuterol standard senzyme labelling antibody, a clenbuterol standard solution, a substrate color developing solution, a beta-excitant class medicine antibody operating solution, a stopping solution and a concentrated coolution, base material color developing solution, beta-excitant drugs antibody working solution, compression cleaning liquid, ending solution and compression twin solution. The invention also disclosemplex solution. The present invention also discloses a method for detecting the beta-excitant class medicines by the enzyme linked immune test kit, which comprises the following steps that a sample iss a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result. firstly preprocessed; then the sample is detected by the enzyme linked immune test kit; finally, the detection result is analyzed. The enzyme linked immune test kit for detecting beta-excitant class medicines can simultaneously and fast detect a large quantity of samples; the detection method has the characteristics of convenience, easy implementation, high specificity, high sensitivity, high precision, high accuracy, etc.
Description
Technical field
The present invention relates to the detection of veterinary drugs in food analysis technical field, particularly, relate to the enzyme linked immunological kit and the method for beta-stimulants in a kind of detection urine, animal tissue's (muscle, liver), the feed.
Background technology
Salbutamol (Salbutamol) and clenbuterol (Clenbuterol) all belong to the beta-receptor excitomotor, the clinical treatment bronchial astehma that is mainly used in; This type of medicine can also once once be widely used in beastly fowl and produce as the growth-promoting agent of ox, sheep, pig, fowl etc.But because that beta-stimulants gathers in animal's liver easily is residual, and can enter human body by food chain, the health of serious harm human body is so EU member country divides this type of medicine into forbidding.Therefore residual detection is necessary to beta-stimulants in the animal foodstuff in reinforcement.
The chemical method that detects the beta-stimulants residual quantity mainly contains thin-layered chromatography (TLC), vapor-phase chromatography (GC), high performance liquid chromatography (HPLC), gas-matter online (GC/MS), liquid-matter online (HPLC/MS) etc., because complicated instrument and equipment and loaded down with trivial details process are not suitable for on-site supervision and great amount of samples examination.
Summary of the invention
(1) technical matters that will solve
The purpose of this invention is to provide a kind of simple in structure, easy to use, low price, portable enzyme linked immunological kit and the method that is used for the animal derived food beta-stimulants.
(2) technical scheme
The present invention is a kind of enzyme linked immunological kit that detects beta-stimulants, it is characterized in that comprising following material:
(1) bag is by the ELISA Plate of beta-stimulants antigen;
(2) enzyme mark antiantibody;
(3) Clenbuterol standard solution;
(4) substrate colour developing liquid;
(5) beta-stimulants antibody working fluid;
(6) concentrated cleaning solution;
(7) stop buffer;
(8) concentrate redissolution liquid.
In the enzyme linked immunological kit of the present invention, ELISA Plate is in preparation process, used coating antigen adopts mixed anhydride method to carry out coupling beta-stimulants haptens and carrier protein and obtains, and carrier protein is ovalbumin, albumin rabbit serum or mouse serum albumin.
In the enzyme linked immunological kit of the present invention, enzyme mark antiantibody adopts glutaraldehyde method or sodium periodate method to obtain on antiantibody marker enzyme is crosslinked.
In the enzyme linked immunological kit of the present invention, marker enzyme can be horseradish peroxidase or bacterium is extracted alkaline phosphatase, and used antiantibody is a goat-anti rabbit antiantibody.
In the enzyme linked immunological kit of the present invention, the standard solution concentration of Clenbuterol is respectively 0 μ g/L, 0.1 μ g/L, 0.3 μ g/L, 0.9 μ g/L, 2.7 μ g/L, 8.1 μ g/L.
In the enzyme linked immunological kit of the present invention, substrate colour developing liquid A liquid is that hydrogen peroxide or urea peroxide, substrate colour developing liquid B liquid are that o-phenylenediamine or tetramethyl benzidine, stop buffer are sulfuric acid or the hydrochloride buffer of 1～2mol/L when marker enzyme is horseradish peroxidase; When marker enzyme be bacterium when extracting alkaline phosphatase substrate colour developing liquid for being the NaOH of 2mol/L to nitro phosphate buffer, stop buffer; Concentrated cleaning solution is the phosphate buffer that contains the 0.8-1.2% polysorbas20; Concentrating redissolution liquid is that 0.01M-0.05M contains 1% caseic phosphate buffer.
In the enzyme linked immunological kit of the present invention, the concentration of beta-stimulants antibody is 0.5-5.0 μ g/L.
The present invention also provides the method for beta-stimulants residual in a kind of test sample, it is characterized in that may further comprise the steps:
(1) sample pre-treatments;
(2) detect with kit;
(3) analyzing and testing result.
Wherein kit test method is for adding standard solution or sample solution and adding antibody working fluid in the ELISA Plate micropore that is coated with beta-stimulants antigen, washing pats dry behind the incubation, add enzyme mark antiantibody then, washing pats dry behind the incubation, colour developing, termination are measured absorbance with microplate reader.
Each the concentration standard solution that is obtained or the mean value (B) of sample absorbance are divided by the absorbance (B of first standard (0 standard)
0) multiply by 100% again, i.e. percentage absorbance.
Percentage absorbance (%)=(B/B
0) * 100%
B is the mean light absorbency value of sample solution in the formula, B
0Be 0 μ g/L, the mean light absorbency value of standard solution.Semilog value with Clenbuterol concentration is an X-axis, the percentage absorbance is a Y-axis, the drawing standard curve map, the concentration of residual Clenbuterol can be read from typical curve in corresponding each sample, utilizes cross reacting rate to calculate the actual concentrations of other beta-stimulants according to Clenbuterol actual concentrations residual in the sample again.
Haptenic synthesizing with the Clenbuterol is intermediate, carries out acylation reaction with succinic anhydride, and the alcoholic extract hydroxyl group acidylate on the Clenbuterol molecular structure is become the carboxyl spacerarm that contains 4 carbon, is prepared into the beta-stimulants haptens.
Immunogene adopts water-soluble carbodiimide method (EDC), mixed anhydride method (isobutyl chlorocarbonate) or active ester method (DCC, NHS) to carry out coupling beta-stimulants haptens and thyroprotein (BCG) and obtains immunogene.
Coating antigen adopts water-soluble carbodiimide method (EDC), mixed anhydride method (isobutyl chlorocarbonate), active ester method (DCC, NHS) to carry out coupling and obtain coating antigen beta-stimulants haptens and albumin rabbit serum (RSA), ovalbumin or mouse serum albumin.
Antibody preparation process of the present invention is as follows:
A. beta-stimulants rabbit polyclonal antibody preparation
Adopt new zealand white rabbit as immune animal, with beta-stimulants haptens and carrier protein couplet thing is immunogene, immunizing dose is 1mg/kg, Freund's complete adjuvant with immunogene and equivalent during first immunisation is mixed and made into emulsifying agent, the subcutaneous multi-point injection of nape portion, getting the same dose immunogene 3-4 week adds equivalent incomplete Freund mixing and emulsifying at interval, and booster immunization is once, immunity is 5 times altogether, does not add adjuvant for the last time.Take a blood sample after last immune 7-10 days, measure serum antibody titer, heart is taken a blood sample, and obtains the polyclonal antibody of purifying through ammonium sulfate precipitation.
B. the preparation of antiantibody is that immunogene is carried out immunity to the pathogen-free domestic goat and obtained goat-anti rabbit antiantibody with rabbit source antibody.
C. the preparation of the preparation enzyme mark antiantibody of enzyme mark antiantibody is that horseradish peroxidase or bacterium are extracted alkaline phosphatase employing sodium periodate method or glutaraldehyde method and antiantibody coupling of goat-anti rabbit and purifying extraction, obtains enzyme mark antiantibody.
ELISA Plate preparation method:
Be cushioned liquid (pH9.6 with bag, 0.05mol/L carbonate buffer solution) beta-stimulants haptens and carrier protein couplet thing are diluted to 0.1-1 μ g/mL, every hole adds 100 μ L, 37 ℃ of incubation 2h and 4 ℃ spend the night, coating buffer inclines, with cleansing solution washing 3 times, each 30 seconds, pat dry, in every hole, add 150-200 μ L confining liquid then, 37 ℃ of incubation 1-2h, liquid in the hole of inclining, preserve with the vacuum seal of aluminium film dry back.
Detection principle of the present invention is: the method that adopts indirect competitive ELISA, on capillary strip, wrap in advance by the conjugate of coupling beta-stimulants haptens and carrier protein, in micropore, add sample solution or series standard product solution and beta-stimulants antibody working fluid, residue Clenbuterol in the sample will be competed beta-stimulants antibody with the coupled antigen of pre-bag quilt on the capillary strip, after adding enzyme mark antiantibody, colour developing; Colour developing stops the back and measures every hole absorbance (OD value) with microplate reader, the content of sample absorbance residue Clenbuterol contained with it is negative correlation, relatively can draw the content of corresponding residue Clenbuterol with typical curve, the content according to the Clenbuterol that obtains utilizes cross reacting rate that other beta-stimulants are calculated again.Also can be according to the depth of the color sample on the ELISA Plate, but with the concentration range of the comparison judgement sample of the standard items liquid color of the Clenbuterol of series concentration.Also can use regression equation method, calculate sample solution concentration.Utilize computer professional software, the express-analysis of a large amount of samples of being more convenient for.
Sample-pretreating method:
A. the tissue sample pulverized of animal tissue: 3.0g adds 15mL acetonitrile-HCl solution and mixes, the 10min that fully vibrates, and reaching the purpose of homogeneous, 10-15 ℃, the above centrifugal 10min of 3000g.Get supernatant 5mL, add 0.1M HCl 5mL, mix back adding 6mL normal hexane and fully mix 2min, the 10-15 ℃ of above centrifugal 5min of 3000g.Remove the normal hexane phase, add 1mL 1M NaOH and mix back adding 6mL methenyl choloride, the 10min that fully vibrates, the 10-15 ℃ of centrifugal 10min of 5000g.Take off a layer phase, decompressing and extracting or nitrogen dry up, and get 1mL and add 1mL redissolution liquid dissolving dried residue again, get 20 μ L and analyze.
B. feed: take by weighing the sample after the 2g homogenate, in sample, add methyl alcohol-ethanol 6mL potpourri again, get supernatant 2mL and add methylene chloride 8mL mixing, standing demix, take off 50 ℃ of evaporated under reduced pressure of layer,, get 20 μ L and analyze with 1mL redissolution liquid dissolving dried residue.
C. urine sample: directly get the limpid urine of 20 μ L and analyze with kit.
(3) beneficial effect
The enzyme linked immunological kit of detection beta-stimulants of the present invention mainly adopts the residual quantity of beta-stimulants in the qualitative or samples such as detection by quantitative animal tissue (muscle, flesh liver), urine and feed of indirect competitive ELISA method; Pre-treatment requirement to sample is low, and sample pretreatment process is simple, simultaneously the fast detecting gross sample.
Used immunogenic carrier protein is a thyroprotein, and that is because the non-antibody that self produces, promptly and the difference of body (by the animal of immunity) own big more that non-self macromolecular substances can finely must produce antibody more.Adopt the beta-stimulants polyclonal antibody, main agents provides with the working fluid form, easy to use, have characteristics such as high specific, high sensitivity, pinpoint accuracy, pin-point accuracy, will in the detection of food and feed beta-stimulants residual quantity, play a significant role.
Description of drawings
Fig. 1: beta-stimulants examination criteria curve map.
Embodiment
Following examples are used to illustrate the present invention, but are not used for limiting the scope of the invention.
The preparation of embodiment 1 reagent constituents
1, antigen preparation
A. haptenic synthesizing with the Clenbuterol is intermediate, carries out acylation reaction with succinic anhydride, the alcoholic extract hydroxyl group acidylate on the Clenbuterol molecular structure become the carboxyl spacerarm that contains 4 carbon be prepared into the beta-stimulants haptens.
B. immunogene adopts mixed anhydride method (isobutyl chlorocarbonate) to carry out coupling beta-stimulants haptens and thyroprotein (BCG) and obtains immunogene.
Immunogenic preparation process: get beta-stimulants haptens 2g and be dissolved in 20mL, 0.5M sodium hydroxide solution in, getting the 1.5g carbodiimides again is dissolved in and is added in the beta-stimulants haptens solution stirring at room reaction 2 hours in the 5mL pure water, get carrier protein 20g and be dissolved in the 75mLpH9.6 carbonate buffer solution, again thyroprotein (BCG) is added drop-wise in the beta-stimulants haptens solution 4 ℃ of stirrings and spends the night.The artificial antigen that has reacted was dialysed 7 days to the phosphate buffer of 0.1M, change liquid every day 3 times.At last antigen is concentrated or the freeze-drying preservation.
C. coating antigen adopts mixed anhydride method (isobutyl chlorocarbonate) to carry out coupling beta-stimulants haptens and human serum albumins (HSA) and obtains coating antigen.
2, Antibody Preparation
A. beta-stimulants rabbit polyclonal antibody preparation
Adopt new zealand white rabbit as immune animal, with beta-stimulants haptens and thyroprotein (BCG) conjugate is immunogene, immunizing dose is 1mg/kg, Freund's complete adjuvant with immunogene and equivalent during first immunisation is mixed and made into emulsifying agent, the subcutaneous multi-point injection of nape portion, getting the same dose immunogene 4 weeks adds equivalent incomplete Freund mixing and emulsifying at interval, and booster immunization is once, immunity is 5 times altogether, does not add adjuvant for the last time.Serum antibody titer is measured in last immunity blood sampling after 10 days, and heart is taken a blood sample, and obtains the polyclonal antibody of purifying with ammonium sulfate precipitation.
B. the preparation of antiantibody is that immunogene is carried out immunity to the pathogen-free domestic goat and obtained goat-anti rabbit antiantibody with rabbit source antibody.
C. the preparation of enzyme mark antiantibody adopts glutaraldehyde method and the antiantibody coupling of goat-anti rabbit and purifying to extract horseradish peroxidase, obtains enzyme mark antiantibody.
The preparation process of enzyme mark antiantibody:
(1) takes by weighing horseradish peroxidase 25mg and be dissolved in 1.25% glutaraldehyde solution, in the room temperature standing over night.
(2) reacted enzyme solutions is used the physiological saline wash-out through Sephadex G-25 chromatographic column.Flow speed control was collected brown effluent at 1mL/ minute, was concentrated into 5mL with poly-diethanol.Place in the 25mL small beaker, slowly stir.
(3) take by weighing 12.5mg and be diluted to 5mL, dropwise add in the enzyme solutions under stirring with physiological saline.
(4) with 1M pH9.5 carbonic acid buffer 0.25mL, continue to stir 3 hours.
(5) add 0.2M lysine 0.25mL, behind the mixing, put room temperature 2 hours.
(6) under agitation dropwise add the equal-volume saturated ammonium sulfate, put 4 ℃ 1 hour.
(7) 3000rpm centrifugal half an hour, abandon supernatant.Sediment is washed secondary with semi-saturation ammonium sulfate, and last sediment is dissolved in the phosphate buffer of a small amount of 0.15M pH7.4.
(8) solution is packed in the bag filter,, remove (detecting) behind the ammonium ion with Nai Shi reagent to the phosphate buffer water dialysis of 0.15M pH7.4,10,000rpm removed precipitation in centrifugal 30 minutes, and supernatant is enzyme conjugates, after the packing, stored frozen.
3, the preparation of ELISA Plate
Be cushioned liquid (pH9.6 with bag, 0.05mol/L carbonate buffer solution) beta-stimulants and human serum albumin conjugate are diluted to 1 μ g/mL, every hole adds 100 μ L, 37 ℃ of incubation 2h or 4 ℃ spend the night, coating buffer inclines, with cleansing solution washing 3 times, each 30 seconds, pat dry, in every hole, add 200 μ L confining liquids (solution that contains 2% lowlenthal serum, 5% cow's serum) then, 37 ℃ of incubation 2h, liquid in the hole of inclining, preserve with the vacuum seal of aluminium film dry back.
Embodiment 2 detects the establishment of the enzyme linked immunological kit of beta-stimulants
Set up the enzyme linked immunological kit that detects beta-stimulants, make it comprise following component:
(1) bag is by the ELISA Plate of Clenbuterol and human serum albumins (HSA) conjugate;
(2) the goat-anti rabbit antiantibody of horseradish peroxidase-labeled;
(3) Clenbuterol standard solution, concentration are respectively 0 μ g/L, 0.1 μ g/L, 0.3 μ g/L, 0.9 μ g/L, 2.7 μ g/L, 8.1 μ g/L;
(4) substrate colour developing liquid A liquid is hydrogen peroxide, and substrate colour developing liquid B liquid is o-phenylenediamine;
(5) concentration of beta-stimulants rabbit polyclonal antibody working fluid is 0.5 μ g/L;
(6) phosphate buffer of concentrated cleaning solution 0.8% polysorbas20 (0.01M, PH7.4);
(7) stop buffer is a 1mol/L hydrochloric acid;
(8) concentrating redissolution liquid is that 0.01M contains 1% caseic phosphate buffer.
Embodiment 3 detects the establishment of the enzyme linked immunological kit of beta-stimulants
Set up the enzyme linked immunological kit that detects beta-stimulants, make it comprise following component:
(1) bag is by the ELISA Plate of beta-stimulants haptens and human serum albumins (HSA) conjugate;
(2) the goat-anti rabbit antiantibody of horseradish peroxidase-labeled;
(3) Clenbuterol standard solution, concentration are respectively 0 μ g/L, 0.1 μ g/L, 0.3 μ g/L, 0.9 μ g/L, 2.7 μ g/L, 8.1 μ g/L;
(4) substrate colour developing liquid A liquid is urea peroxide, and substrate colour developing liquid B liquid is tetramethyl benzidine;
(5) concentration of beta-stimulants rabbit polyclonal antibody working fluid is 5.0 μ g/L;
(6) concentrated cleaning solution is the phosphate buffer of 1.2% polysorbas20;
(7) stop buffer is a 2mol/L sulfuric acid;
(8) concentrating redissolution liquid is that 0.05M contains 1% caseic phosphate buffer.
Embodiment 3 detects the establishment of the enzyme linked immunological kit of beta-stimulants
Set up the enzyme linked immunological kit that detects beta-stimulants, make it comprise following component:
(1) bag is by the ELISA Plate of beta-stimulants haptens and human serum albumins (HSA) conjugate;
(2) the goat-anti rabbit antiantibody of alkaline phosphate ester enzyme labeling;
(3) Clenbuterol standard solution, concentration are respectively 0 μ g/L, 0.1 μ g/L, 0.3 μ g/L, 0.9 μ g/L, 2.7 μ g/L, 8.1 μ g/L;
(4) substrate solution is to the nitro phosphate buffer;
(5) concentration of beta-stimulants antibody working fluid is 5.0 μ g/L;
(6) concentrated cleaning solution is the phosphate buffer of 1.2% polysorbas20;
(7) stop buffer is a 2mol/L NaOH damping fluid;
(8) concentrating redissolution liquid is that 0.05M contains 1% caseic phosphate buffer.
Embodiment 4 detects residual beta-stimulants in the pork
(1) sample pre-treatments
The tissue sample (low fat) that animal tissue: 3.0g pulverizes adds 15mL acetonitrile-HCl solution and mixes, the 10min that fully vibrates, and reaching the purpose of homogeneous, 10 ℃, the centrifugal 10min of 4000g.Get supernatant 5mL, add 0.1MHCl 5mL, mix back adding 6mL normal hexane and fully mix 2min, 15 ℃ of centrifugal 5min of 4000g.Remove the normal hexane phase, add 1mL1M NaOH and mix back adding 6mL methenyl choloride, the 10min that fully vibrates, the 10-15 ℃ of centrifugal 10min of 5000g.Take off a layer phase, decompressing and extracting or nitrogen dry up, and add 1mL redissolution liquid dissolving dried residue, get 20 μ L and analyze with kit.
(2) detect with kit
In the ELISA Plate micropore of beta-stimulants haptens and human serum albumins (HSA) conjugate bag quilt, add series standard solution or sample solution (each 2 hole) 20 μ L, add beta-stimulants antibody working fluid 80 μ L then, with cover plate film shrouding, react 30min in 37 ℃ of constant temperature ovens.Pour out liquid in the hole, every hole adds 250 μ L cleansing solutions, pours out liquid in the hole after 30 seconds, and so repetitive operation is washed plate 5 times altogether, pats dry with thieving paper.The goat-anti rabbit antiantibody working fluid 100 μ L that add horseradish peroxidase-labeled with cover plate film shrouding, react 30min in 37 ℃ of constant temperature ovens.Take out ELISA Plate, wash plate as described above 5 times.Every hole adds substrate colour developing liquid A liquid 50 μ L, adds B liquid 50 μ L again, the mixing that vibrates gently, 37 ℃ of constant temperature oven lucifuge colour developing 15min.Every hole adds stop buffer 50 μ L, and the mixing that vibrates is gently measured every hole absorbance (OD value) with microplate reader.
(3) interpretation of result
Calculate the percentage absorbance, the drawing standard curve:
Each the concentration standard solution that is obtained or the mean value (B) of sample absorbance are divided by the absorbance (B of first standard (0 standard)
0) multiply by 100% again, i.e. percentage absorbance.
Percentage absorbance (%)=(B/B
0) * 100%
B is the mean light absorbency value of standard solution or sample solution in the formula, B
0It is the mean light absorbency value of 0 μ g/L standard solution.Natural logarithm value with Clenbuterol concentration is an X-axis, the percentage absorbance is a Y-axis, the drawing standard curve map, as shown in Figure 1, the concentration of residual Clenbuterol can be read from typical curve in corresponding each sample, utilizes cross reacting rate to calculate the residual quantity of other beta-stimulants according to the residual quantity of Clenbuterol again.
The beta-stimulants that embodiment 5 detects in the feed
1, sample pre-treatments:
Feed: take by weighing the sample after the 2g homogenate, add methyl alcohol-ethanol 6mL potpourri again in sample, get supernatant 2mL and add methylene chloride 8mL mixing, standing demix takes off 50 ℃ of evaporated under reduced pressure of layer, redissolves liquid dissolving dried residue with 1mL, gets 20 μ L and analyzes.
2, detect with kit
In the ELISA Plate micropore of beta-stimulants haptens and human serum albumins (HSA) conjugate bag quilt, add series standard solution or sample solution (each 2 hole) 20 μ L, add beta-stimulants polyclonal antibody working fluid 80 μ L then, with cover plate film shrouding, react 30min in 37 ℃ of constant temperature ovens.Pour out liquid in the hole, every hole adds 250 μ L cleansing solutions, pours out liquid in the hole after 30 seconds, and so repetitive operation is washed plate 5 times altogether, pats dry with thieving paper.The goat-anti rabbit antiantibody working fluid 100 μ L that add horseradish peroxidase-labeled with cover plate film shrouding, react 30min in 37 ℃ of constant temperature ovens.Take out ELISA Plate, wash plate as described above 5 times.Every hole adds substrate colour developing liquid A liquid 50 μ L, adds B liquid 50 μ L again, the mixing that vibrates gently, 37 ℃ of constant temperature oven lucifuge colour developing 30min.Every hole adds stop buffer 50 μ L, and the mixing that vibrates is gently measured every hole absorbance (OD value) with microplate reader.
(3) interpretation of result
With embodiment 4 (3).
The beta-stimulants that embodiment 6 detects in the urine
Sample pre-treatments: directly get 20 μ L urine samples and analyze with kit.
Kit detection and interpretation of result method are with embodiment 4.
Embodiment 7 kit precision, accuracy and storage life test
(1) kit precision test
The repeatable test of standard: extract 10 kits respectively from three batches of kits, each kit takes out 20 micropores, measures the absorbance of 4.5 μ g/L standard solution and calculates the coefficient of variation, and measurement result sees Table 1.
The repeatable test of table 1 standard (CV%)
10 standard coefficient of variation of three batches of kits measurement range is between 6.5%～11.6%, therefore meet precision and be less than or equal to 20% regulation, illustrate that this kit standard items precision has reached " Ministry of Agriculture's file " farming doctor and sent out [2005] No. 17 annex 2 kits and put on record with reference to the precision standard of the 4th precision in the judgment criteria and accuracy.
The repeatable test of sample: get the Clenbuterol standard items sample is added, get each three of the kits of three different batches respectively, each concentration repeats 5 times, calculates the coefficient of variation respectively.
The repeatable test of table 2 pork sample
The repeatable test of table 3 pig urine samples
The repeatable test of table 4 feed sample
The result shows that the Variation Lines number average of pork sample is less than 20%, the Variation Lines number average of pig urine samples is less than 21%, the Variation Lines number average of feed sample is less than 22%, met the coefficient of variation less than 35% regulation, illustrated that precision that this kit sample is measured has reached " Ministry of Agriculture's file " farming doctor and sent out [2005] No. 17 annex 2 kits and put on record with reference to the precision standard of the 4th precision in the judgment criteria and accuracy.
(2) test of accuracy
Get the Clenbuterol standard solution of two concentration, be respectively 1 μ g/kg (L) and 2 μ g/kg (L), respectively sample is added recovery test, each concentration do 4 parallel, calculate recovery rate respectively.
The accuracy of table 5 kit
The result shows the recovery of pig urine interpolation between 65.8%～108.5%, and honey adds the recovery between 76.5%～123.1%, adds the recovery in the chicken between 79.3%～116.3%.
(3) specificity
Specificity represents that with cross reacting rate cross reacting rate is meant the ability of the antigenic determinant generation combination that antibody is different with structure.Cross reacting rate is little, the specificity height of provable antibody.
Select and the four kind medicines of Clenbuterol,, substitute the Clenbuterol standard solution, measure its typical curve, and calculate IC the Clenbuterol analog of variable concentrations with similar structure and similar functions
50Inhibition concentration is calculated cross reacting rate.
Table 6 cross reaction
(4) kit storage life test
Kit storage life condition is 2-8 ℃, and through 6 months mensuration, the maximum absorbance value (zero standard) of kit, 50% inhibition concentration, Clenbuterol medicine added the practical measurement value all within normal range.Consideration has improper preservation condition and occurs in transportation and use, and kit was placed 6 days under the condition of 37 ℃ of preservations, carries out the accelerated deterioration experiment, and the result shows that the every index of this kit meets the requirements fully.Consider that the freezing situation of kit takes place, kit was put into-20 ℃ of refrigerators freezing 5 days, measurement result shows that also the every index of kit is normal fully.Can draw kit from above result can preserve more than 6 months at 2-8 ℃.
Claims (9)
1, a kind of enzyme linked immunological kit that detects beta-stimulants is characterized in that it comprises:
(1) bag is by the ELISA Plate of beta-stimulants antigen;
(2) enzyme mark antiantibody;
(3) Clenbuterol standard solution;
(4) substrate colour developing liquid;
(5) beta-stimulants antibody working fluid;
(6) concentrated cleaning solution;
(7) stop buffer;
(8) concentrate redissolution liquid,
Wherein, described beta-stimulants antigen is to be intermediate with the Clenbuterol, carry out acylation reaction with succinic anhydride, alcoholic extract hydroxyl group acidylate on the Clenbuterol molecular structure is become the carboxyl spacerarm that contains 4 carbon be prepared into the beta-stimulants haptens, more described haptens and carrier protein couplet are obtained; Described beta-stimulants antibody is to be obtained by described antigen-immunized animal.
2, enzyme linked immunological kit as claimed in claim 1, it is characterized in that described ELISA Plate is in preparation process, used coating antigen adopts mixed anhydride method to carry out coupling beta-stimulants haptens and carrier protein and obtains, and carrier protein is ovalbumin, albumin rabbit serum or mouse serum albumin.
3, enzyme linked immunological kit as claimed in claim 1 is characterized in that described enzyme mark antiantibody adopts glutaraldehyde method or sodium periodate method to obtain marker enzyme is crosslinked on antiantibody.
4, enzyme linked immunological kit as claimed in claim 3 is characterized in that described marker enzyme is that horseradish peroxidase or bacterium are extracted alkaline phosphatase.
5, enzyme linked immunological kit as claimed in claim 1 is characterized in that the standard solution concentration of described Clenbuterol is respectively 0 μ g/L, 0.1 μ g/L, 0.3 μ g/L, 0.9 μ g/L, 2.7 μ g/L, 8.1 μ g/L.
6, enzyme linked immunological kit as claimed in claim 1, it is characterized in that: when marker enzyme was horseradish peroxidase, substrate colour developing liquid A liquid was that hydrogen peroxide or urea peroxide, substrate colour developing liquid B liquid are that o-phenylenediamine or tetramethyl benzidine, stop buffer are sulfuric acid or the hydrochloride buffer of 1～2mol/L; When marker enzyme is a bacterium when extracting alkaline phosphatase, substrate colour developing liquid is for being the NaOH of 2mol/L to nitro phosphate buffer, stop buffer; Concentrated cleaning solution is the phosphate buffer that contains the 0.8-1.2% polysorbas20; Concentrating redissolution liquid is that 0.01M-0.05M contains 1% caseic phosphate buffer.
7, enzyme linked immunological kit as claimed in claim 1, the concentration that it is characterized in that described beta-stimulants antibody are 0.5-5.0 μ g/L.
8, the method for residual beta-stimulants in a kind of test sample is characterized in that may further comprise the steps:
(1) sample pre-treatments;
(2) the described kit of arbitrary claim 1-7 detects;
(3) analyzing and testing result.
9, method as claimed in claim 8, wherein kit test method is for adding standard solution or sample solution and adding antibody working fluid in the ELISA Plate micropore that is coated with beta-stimulants antigen, washing pats dry behind the incubation, add enzyme mark antiantibody then, washing pats dry behind the incubation, colour developing, termination are measured absorbance with microplate reader.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100867690A CN100501404C (en) | 2005-11-03 | 2005-11-03 | ELISA kit for detecting beta-stimulants and detection method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100867690A CN100501404C (en) | 2005-11-03 | 2005-11-03 | ELISA kit for detecting beta-stimulants and detection method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1766617A CN1766617A (en) | 2006-05-03 |
| CN100501404C true CN100501404C (en) | 2009-06-17 |
Family
ID=36742622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100867690A Expired - Fee Related CN100501404C (en) | 2005-11-03 | 2005-11-03 | ELISA kit for detecting beta-stimulants and detection method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100501404C (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1885038B (en) * | 2006-07-11 | 2010-08-18 | 华南农业大学 | ELISA kit for detecting clenbuterol and detection method thereof, and animal tissue sample preparing method before detection |
| CN101256188B (en) * | 2008-04-16 | 2012-07-11 | 北京望尔生物技术有限公司 | ELISA kit for detecting lincomycin medicine as well as usage thereof |
| CN101993486B (en) * | 2009-08-27 | 2014-10-08 | 深圳市三方圆生物科技有限公司 | Clenbuterol immunogen, coatingen and application thereof in colloidal gold test paper |
| CN102359961B (en) * | 2011-08-18 | 2014-11-19 | 南京量子化工科技有限公司 | Kit for detecting estrol or beta-adrenocepter agonist compounds, its method and application |
| CN102707073A (en) * | 2012-06-21 | 2012-10-03 | 江苏大学 | Enzyme linked immunosorbent assay kit for detecting metandienone and using method of enzyme linked immunosorbent assay kit |
| CN103513041A (en) * | 2012-06-29 | 2014-01-15 | 内蒙古蒙牛乳业（集团）股份有限公司 | Method for detecting beta-agonist in raw milk |
| CN103592434B (en) * | 2013-03-21 | 2015-11-25 | 浙江迪恩生物科技股份有限公司 | Detect one-step enzyme-linked immunoassay method and the kit thereof of beta-stimulants class |
| CN103630689B (en) * | 2013-12-03 | 2015-08-05 | 河北省科学院生物研究所 | A kind ofly detect enzyme linked immunological kit of Cimaterol medicament residue and preparation method thereof and application |
| CN104892442A (en) * | 2014-03-07 | 2015-09-09 | 北京维德维康生物技术有限公司 | Clenbuterol hapten and antigen and dedicated chemiluminescence immune kit |
| CN106706934B (en) * | 2016-12-08 | 2017-12-01 | 河北省科学院生物研究所 | A kind of enzyme linked immunological kit for detecting Formoterol and preparation method and application |
| CN110133306B (en) * | 2019-05-09 | 2023-04-07 | 北京勤邦生物技术有限公司 | Enzyme linked immunosorbent assay kit for detecting cimaterol and application thereof |
| CN113237875A (en) * | 2021-04-27 | 2021-08-10 | 安徽省产品质量监督检验研究院（国家排灌及节水设备产品质量监督检验中心） | Detection method for rapidly detecting beta-stimulant and paper-based immunosensor |
-
2005
- 2005-11-03 CN CNB2005100867690A patent/CN100501404C/en not_active Expired - Fee Related
Non-Patent Citations (8)
| Title |
|---|
| 沙丁胺醇单克隆抗体的制备及其鉴定. 邱阳生等.中国兽医科技，第32卷第10期. 2002 |
| 沙丁胺醇单克隆抗体的制备及其鉴定. 邱阳生等.中国兽医科技，第32卷第10期. 2002 * |
| 猪肝和猪尿中沙丁胺醇和克伦特罗残留的酶联免疫吸附检测方法研究. 王建平等.兽牧兽医学报，第36卷第4期. 2005 |
| 猪肝和猪尿中沙丁胺醇和克伦特罗残留的酶联免疫吸附检测方法研究. 王建平等.兽牧兽医学报，第36卷第4期. 2005 * |
| 盐酸克伦特罗免疫原的合成与鉴定. 贺铁明等.中国粮油学报，第19卷第2期. 2004 |
| 盐酸克伦特罗免疫原的合成与鉴定. 贺铁明等.中国粮油学报，第19卷第2期. 2004 * |
| 盐酸克伦特罗的酶联免疫分析试剂盒的研制－I克伦特罗人工抗原及抗体的制备. 李利东等.中国卫生检验杂志，第14卷第1期. 2004 |
| 盐酸克伦特罗的酶联免疫分析试剂盒的研制－I克伦特罗人工抗原及抗体的制备. 李利东等.中国卫生检验杂志，第14卷第1期. 2004 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1766617A (en) | 2006-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100501404C (en) | ELISA kit for detecting beta-stimulants and detection method thereof | |
| CN101013129B (en) | Enzyme linked immunosorbent reagent casing for detecting furacilin metabolite and uses thereof | |
| CN101256188B (en) | ELISA kit for detecting lincomycin medicine as well as usage thereof | |
| CN103018450B (en) | A kind of preparation method of chemical luminescence ELISA detection kit of chloromycetin | |
| CN100501410C (en) | ELISA kit for detecting ractopamine in animal derived food | |
| CN101571539B (en) | Elisa kit for detecting cephalo-type medicine and application thereof | |
| CN101571541B (en) | Enzyme-linked immunosorbent inspect kit for inspecting sulfa drugs and method thereof | |
| CN100501409C (en) | ELISA kit for detecting chloramphenicols in animal derived food | |
| CN101021536B (en) | Enzyme-linked immunological kit for detecting neomycin drug and method | |
| CN100445746C (en) | Method for detecting 19-nortestosterone and special enzyme-linked immune reagent kit thereof | |
| CN101013130A (en) | Enzyme linked immunosorbent reagent casing for detecting furantoin metabolite and uses thereof | |
| CN101021535B (en) | Enzyme-linked immunalogical kit for detecting gentamicin medicine and method | |
| CN103575890A (en) | Chemiluminescence assay kit of ractopamine (RAC) and application thereof | |
| CN100501405C (en) | ELISA kit for detecting penicillin G and detection method thereof | |
| CN1811436B (en) | Method for detecting Ennoxacin and its special enzyme-linked immune reagent kit | |
| CN101799469A (en) | Enzyme linked immunosorbent assay kit for detecting residual clenbuterol hydrochloride and a detection method thereof | |
| CN103012592A (en) | Preparation and applications of ractopamine monoclonal antibody | |
| CN100489530C (en) | Method for assaying sulfaquinoxaline and special enzyme-linked immune reagent kit | |
| CN101358967B (en) | Method for detecting chlorpromazine and special ELISA kit thereof | |
| CN101013131B (en) | Furantoin metabolite enzyme linked immunosorbent analytical reagent casing and uses thereof | |
| CN101776685A (en) | Enzyme linked immunosorbent assay kit for detecting trimethoprim medicament and application thereof | |
| CN106324240A (en) | Enzyme-linked immunoassay kit for detecting chlorpyrifos and application of kit | |
| CN100476439C (en) | ELISA kit for detecting quinolones in animal derived food | |
| CN101403752A (en) | Chemical luminescence ELISA detection kit for gatifloxacin | |
| CN100533148C (en) | Method for detecting tylosin and special enzyme-linked immune reagent kit thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20091009 Pledge (preservation): Pledge |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20100901 Granted publication date: 20090617 Pledgee: Zhongguancun Beijing science and technology Company limited by guarantee Pledgor: Beijing Wanger Biotechnology Co.,Ltd. Registration number: 2009110000623 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090617 |